Ulcerative colitis patients treated with the biological treatment had significantly decreased median fluorescence intensity of CD44 on CD14+CD16++ monocytes in comparison to CD patients treated with biological therapy, which exhibited no significant difference in this parameter from the control group (Figure 3). The gene discussed is CD44; the disease is ulcerative colitis.